ClinicalTrials.gg
RecruitingNCT07383740Updated Aug 20, 2026

Test-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis

An interventional study of Submaximal cycle ergometer test-retest in Osteo Arthritis Knee and Hip, sponsored by Vastra Gotaland Region. Recruiting at 1 site in Sweden. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2026-08-20.

Primary conditionOsteoarthritis, KneeRegistry: OsteoarthritisReclassifiedWhy we changed it
Registry
Osteoarthritis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Osteoarthritis, Knee
Why
  1. The study's title name Osteoarthritis, Knee, a narrower term within Osteoarthritis.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Vastra Gotaland Region · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
30 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Osteoarthritis, Knee by Vastra Gotaland Region — 3 open to participants now, 6 under way, none of them phase 3. Osteoarthritis, Knee · Vastra Gotaland Region.

Started
2026
with 1 other
No phase
7 of 10
3 open now
Registered
10th of 10
by date

Among the 10 studies in Osteoarthritis, Knee by Vastra Gotaland Region, this one is one of 2 that started in 2026, is one of 7 with no phase, and was the 10th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

3 of the 10 studies in Osteoarthritis, Knee by Vastra Gotaland Region are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 30 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Osteoarthritis, Knee by Vastra Gotaland Region, or all of them as a file.
02

Study summary

The aim is to evaluate the test-retest reliability of the primary care-adapted Ekblom-Bak submaximal ergometer bicycle test in patients with hip- and/or knee osteoarthritis (OA).

Forty patients with hip- and/or knee OA eligible for the Swedish national OA treatment program in primary care are to be recruited. After screening for contraindications, participants will perform the aEB-test twice within 1-2 weeks.

The investigators hypothezise that the test will demonstrate acceptable test-retest reliability in patients with hip- and/or knee OA.

To establish reliability is essential for future studies using this test in this population and may support its integration into routine clinical assessment.

03

Conditions studied

  • Osteo Arthritis Knee and Hip

Browse trials for

Keywords

  • Osteoarthritis
  • knee osteoarthritis
  • hip osteoarthritis
  • exercise test
  • reliability
  • cardiorespiratory fitness
  • test-retest
04

In context

Osteoarthritis, Knee Reclassified

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

This study's planned enrollment of 40 is below the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Vastra Gotaland Region is the lead sponsor of 276 studies on the registry; 110 are open to participants now.

Compared within Osteoarthritis, Knee, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Osteoarthritis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Currently listed on the waiting list for an osteoarthritis rehabilitation program due to clinically diagnosed hip and/or knee osteoarthritis.

Exclusion criteria

Exclusion Criteria:

  • Another primary cause of symptoms or disability, such as inflammatory joint disease or fracture.
  • Another condition currently causing more symptoms than osteoarthritis, for example fibromyalgia.
  • Insufficient understanding of written and spoken Swedish.
  • Medication that affects heart rate.
  • for a submaximal ergometer bicycle test according to the screening protocol, such as heart disease.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

06

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Forty patients with osteoarthritis in hip or knee

    Forty patients with hip or knee osteoarthritis on the waiting list for usual rehabilitation care will be recruited. The patientes will be screened for contraindications, and, if eligible, will complete a submaximal cycle ergometer test twice within one week.

    Procedure: Submaximal cycle ergometer test-retest

Interventions

  • ProcedureSubmaximal cycle ergometer test-retest

    Performing a submaximal cycle ergometer test twice

07

What researchers measure

Primary outcomes

  1. Estimated VO2-max value.

    An estimated VO2-max value is obtained by performing the Ekblom Bak submaximal cycle ergometer test.

    Time frame: Time between first and second submaximal cycle ergometer test should be one week.

08

Study locations

1 of 1 sites recruiting
09

References and documents

Related links

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Sep 2027, 16 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 16 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 19, 2026
First posted
Feb 3, 2026
StartActual
Apr 21, 2026
Primary completionEst.
Sep 1, 2027
CompletionEst.
Oct 1, 2027
Last update
Aug 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07383740
Responsible party
Sponsor
First posted
Feb 3, 2026
Start date
Apr 21, 2026
Primary completion
Sep 1, 2027 (estimated)
Completion
Oct 1, 2027 (estimated)
Last update
Aug 20, 2026

Study contacts

Daniel Karsberg Zotterman, MSc
Contact
daniel.karsberg.zotterman@vgregion.se
+46739298119
Stefan Lundqvist, PhD
Contact
stefan.lundqvist@vgregion.se
+46762276179

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion